Hi I am curious if anyone has found a chart or info on how much interferon, ribavirin and telaprevir a person should take based on their weight. Maybe some of these are not even weight based altho it sure seems like a 100# person would not require as much of any of these as a 300# person but I don't know. If anyone has a link to this or a chart or any info, I'm just curious to know. Thankx
I recently asked this same question so if you go to my profile you can see past responses. As far as I know, it's the Ribavirin that is weight based. I am 114 and they have me on 1000 mg a day. This is right, the high end. I feel fine, no sides as a yet.
A relationship between RBV dose and response to therapy with both IFN alpha-2a and alpha-2b has been established in genotype 1 patients, who beneﬁt from doses that exceed 800 mg/day (5, 14). When RBV is combined with PEG-IFN alpha-2a, relatively small reductions to 800 mg/day lead to significantly lower rates of SVR (5). Similarly, a large comparative trial of fixed-dose RBV compared with weight-based dosing in combination with PEG-IFN alpha-2b demonstrated that stratifying patients of all genotypes to receive starting doses ranging from 800-1400 mg/day depending on weight effects higher SVR rates than using a fixed dose of 800 mg/day for all patients (7). A detailed analysis of the relationship between body weight and SVR has suggested that the dose per kilogram is the determining factor of response in genotype 1 patients, based on the 40% to 50% rise in SVR for a 12-16-mg/kg increase in RBV dose (23). RBV dose by weight may impact its concentration in plasma, which also correlates with the response. Although this relationship has been well documented in genotype 1 patients, the data are less clear for other genotypes. A relationship between response and plasma concentration has been proposed for non-genotype 1 patients (24). However Snoeck et al. observed no effect of dose per kilogram body weight on SVR in genotype 2/3 patients (23).
Based on these data, weight-based dosing has been used more extensively in patients with genotype 1 HCV, and it is required to achieve maximum efficacy. The standard initial dose of RBV in patients with HCV genotype 1 is 1000/1200 mg/day (1000 mg/day ≤ 75 kg; 1200 mg/day > 75 kg) over a 48 weeks, although higher RBV doses are considered for patients > 85 kg. A study of 380 patients has shown that the pharmacokinetics of RBV vary widely, wherein lean body weight emerges as the only factor that inﬂuences clearance, supporting the use of these two distinct weight-based doses in patients with genotype 1 disease (25). Although data modeling from patients who received this standard starting dose suggests that SVR increases linearly with RBV doses that equate to > 10 mg/kg, the rate of anemia also rises linearly simultaneously (< 10 g/dL hemoglobin) (23). An RBV dose of 15 mg/kg/day might achieve the best balance between efficacy and a manageable safety proﬁle.
In the Telaprevir (Incivek) trials the ribavirin dosage was either 1000 mg or 1200 mg daily. I don't know the conversion chart they used but I would think 65 kg or below 1000 mg. Above 65 kg 1200 mg. According to HGB level drops, ribavrin dose reduction was given if necessary.
Telaprevir trials used Pegasys (peginterferon alfa-2a) 180 mcg universally. Pegasys is not given as an individualized weight-based dosing like PegIntron (peginterferon alfa-2b)
Incivek is administered two tablets 375 mg ea - 3 times a day every seven to nine hours universally.
Copyright 1994-2016 MedHelp International. All rights reserved.
MedHelp is a division of Aptus Health.
This site complies with the HONcode standard for trustworthy health information.
The Content on this Site is presented in a summary fashion, and is intended to be used for educational and entertainment purposes only. It is not intended to be and should not be interpreted as medical advice or a diagnosis of any health or fitness problem, condition or disease; or a recommendation for a specific test, doctor, care provider, procedure, treatment plan, product, or course of action. Med Help International, Inc. is not a medical or healthcare provider and your use of this Site does not create a doctor / patient relationship. We disclaim all responsibility for the professional qualifications and licensing of, and services provided by, any physician or other health providers posting on or otherwise referred to on this Site and/or any Third Party Site. Never disregard the medical advice of your physician or health professional, or delay in seeking such advice, because of something you read on this Site. We offer this Site AS IS and without any warranties. By using this Site you agree to the following Terms and Conditions. If you think you may have a medical emergency, call your physician or 911 immediately.